NCT05003141 2022-03-28
PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
Phase 1 Unknown
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
Centaurus Biopharma Co., Ltd.